HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leif Hove-Madsen Selected Research

Caffeine (No Doz)

11/2016Suppression of ryanodine receptor function prolongs Ca2+ release refractoriness and promotes cardiac alternans in intact hearts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Leif Hove-Madsen Research Topics

Disease

19Atrial Fibrillation
01/2024 - 09/2004
5Hypoxia (Hypoxemia)
02/2023 - 10/2007
4Cardiomegaly (Heart Hypertrophy)
11/2023 - 06/2013
3Heart Diseases (Heart Disease)
01/2023 - 04/2015
3Polymorphic catecholergic ventricular tachycardia
01/2021 - 08/2013
3Ventricular Tachycardia
01/2018 - 11/2006
3Heart Failure
01/2018 - 11/2006
3Cardiac Arrhythmias (Arrythmia)
11/2016 - 07/2011
2Inflammation (Inflammations)
02/2023 - 03/2021
2Ischemia
02/2023 - 05/2011
1Cardiovascular Diseases (Cardiovascular Disease)
11/2023
1Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2021
1Fibrosis (Cirrhosis)
01/2020
1Sudden Death
01/2018
1Hypertrophy
01/2018
1Left Ventricular Dysfunction
01/2018
1Atrial Remodeling
01/2018
1Bradycardia
11/2016
1Progeria (Hutchinson Gilford Syndrome)
11/2016
1Inborn Genetic Diseases (Disease, Hereditary)
11/2016
1Long QT Syndrome
06/2013
1Myocardial Infarction
06/2012
1Cardiomyopathies (Cardiomyopathy)
06/2011
1Ventricular Fibrillation
11/2009

Drug/Important Bio-Agent (IBA)

20CalciumIBA
06/2023 - 09/2004
7Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
01/2023 - 11/2006
5Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
02/2023 - 03/2011
3Cyclic AMP (AMP, Cyclic)IBA
02/2023 - 11/2006
3Proteins (Proteins, Gene)FDA Link
02/2023 - 08/2015
2Ion Channels (Ion Channel)IBA
01/2024 - 06/2013
2EnzymesIBA
11/2023 - 01/2020
2Adenosine (Adenocard)FDA LinkGeneric
02/2023 - 11/2009
2Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA
08/2015 - 06/2012
2VLDL LipoproteinsIBA
06/2012 - 05/2011
2LipidsIBA
06/2012 - 05/2011
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
11/2023
1Transcription Factors (Transcription Factor)IBA
06/2023
1Long Noncoding RNAIBA
01/2022
1CatecholaminesIBA
01/2021
1Angiotensin IIIBA
01/2020
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
01/2020
1Isoproterenol (Isoprenaline)FDA LinkGeneric
11/2016
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
11/2016
1prelamin AIBA
11/2016
1Caffeine (No Doz)FDA LinkGeneric
11/2016
1Carvedilol (Coreg)FDA LinkGeneric
11/2016
1MicroRNAs (MicroRNA)IBA
10/2016
1LDL Receptors (LDL Receptor)IBA
08/2015
1Small Interfering RNA (siRNA)IBA
08/2015
1Focal Adhesion Kinase 2IBA
08/2015
1Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA
08/2015
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2015
1phospholambanIBA
08/2013
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2013
1Sodium Channels (Sodium Channel)IBA
06/2013
1Potassium Channels (Potassium Channel)IBA
06/2013
1Lipoprotein Receptors (Lipoprotein Receptor)IBA
06/2012
1Cholesterol Esters (Cholesteryl Esters)IBA
06/2012
1RNA (Ribonucleic Acid)IBA
06/2012
1VLDL receptorIBA
05/2011
1Sodium-Calcium ExchangerIBA
11/2009
1Propranolol (Inderal)FDA LinkGeneric
11/2009
15- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA
11/2009
12- (2- (4- (4- nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonateIBA
11/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2007

Therapy/Procedure

1Electrodes (Electrode)
01/2018